We are live on ! Find out more
PVLA

Palvella Therapeutics

100 hedge funds and large institutions have $534M invested in Palvella Therapeutics in 2025 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 9

301% more capital invested

Capital invested by funds: $133M → $534M (+$401M)

208% more call options, than puts

Call options by funds: $984K | Put options by funds: $320K

49% more funds holding

Funds holding: 67100 (+33)

23.63% more ownership

Funds ownership: 53.45%77.09% (+24%)

20% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 20

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
100
Holders Change
+33
Holders Change %
+49.25%
% of All Funds
1.31%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
42
Increased
24
Reduced
20
Closed
9
Calls
$984K
Puts
$320K
Net Calls
+$664K
Net Calls Change
+$396K
Name Holding Trade Value Shares
Change
Change in
Stake
TRCT
76
Tower Research Capital (TRC)
New York
$28.1K +$11.5K +257 +134%
AIC
77
Archer Investment Corporation
Indiana
$28.1K +$20K +449 New
California State Teachers Retirement System (CalSTRS)
78
California State Teachers Retirement System (CalSTRS)
California
$26.9K +$45 +1 +0.2%
US Bancorp
79
US Bancorp
Minnesota
$19.8K +$14.1K +316 New
Citigroup
80
Citigroup
New York
$17.3K -$95.9K -2,150 -89%
AB
81
Amalgamated Bank
New York
$15K
CWIG
82
Chung Wu Investment Group
Texas
$12.5K +$8.92K +200 New
Group One Trading
83
Group One Trading
Illinois
$8.28K
AAP
84
Arax Advisory Partners
Colorado
$5.7K +$4.06K +91 New
VWWMG
85
Vermillion & White Wealth Management Group
Pennsylvania
$5.52K
Comerica Bank
86
Comerica Bank
Texas
$3.57K +$2.54K +57 New
PTC
87
Private Trust Company
Ohio
$3.2K +$2.27K +51 New
SCM
88
Sterling Capital Management
North Carolina
$2.95K +$892 +20 +74%
SPIA
89
Steward Partners Investment Advisory
New York
$1.25K +$892 +20 New
GI
90
GAMMA Investing
California
$1.07K +$758 +17 New
Carson Wealth (CWM LLC)
91
Carson Wealth (CWM LLC)
Nebraska
$1K +$758 +17 New
TC
92
Truvestments Capital
Florida
$878
Osaic Holdings
93
Osaic Holdings
Arizona
$878 +$624 +14 New
PE
94
Point72 Europe
United Kingdom
$728 +$535 +12 New
PNC Financial Services Group
95
PNC Financial Services Group
Pennsylvania
$627 +$446 +10 New
QCG
96
Quadrant Capital Group
Ohio
$627 +$446 +10 New
FFA
97
Farther Finance Advisors
California
$439 +$178 +4 +133%
AF
98
Allworth Financial
California
$314
FC
99
Financial Consulate
Maryland
$314 +$223 +5 New
Jones Financial Companies
100
Jones Financial Companies
Missouri
$238 +$45 +1 +33%

PVLA Hedge Fund Activity: Q3 2025 in Review

100 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Palvella Therapeutics (PVLA) for Q3 2025, worth a combined $534M — up 301% from $133M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new PVLA positions and 9 closed out — a net gain of 33 holders — while 24 added to existing stakes and 20 trimmed.

The largest buyer was First Light Asset Management, opening a new position worth an estimated $24.1M. The largest seller was Millennium Management, cutting an estimated $12.8M.

  • 100 institutional investors held Palvella Therapeutics (PVLA) as of Q3 2025, up from 67 in Q2 2025.
  • Funds reported $534M of Palvella Therapeutics stock for Q3 2025, up 301% quarter-over-quarter.
  • 42 funds opened new Palvella Therapeutics positions in Q3 2025 and 9 closed out, a net change of +33 holders.
  • The largest Palvella Therapeutics buyer in Q3 2025 was First Light Asset Management, an estimated $24.1M added.
  • The largest Palvella Therapeutics seller in Q3 2025 was Millennium Management, an estimated $12.8M sold.

Based on aggregated 13F filings for Q3 2025.